Skip to main content

Peer Review reports

From: Sustained response to pembrolizumab in recurrent perivascular epithelioid cell tumor with elevated expression of programmed death ligand: a case report

Original Submission
24 Feb 2021 Submitted Original manuscript
29 May 2021 Reviewed Reviewer Report - Krishna Sharan
1 Jun 2021 Reviewed Reviewer Report - Ciniraj Raveendran
Resubmission - Version 2
Submitted Manuscript version 2
2 Jun 2021 Editorially accepted
24 Jul 2021 Article published 10.1186/s13256-021-02997-x

You can find further information about peer review here.

Back to article page